Retractable Technologies (NYSE:RVP – Get Free Report) and Hyperfine (NASDAQ:HYPR – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.
Valuation and Earnings
This table compares Retractable Technologies and Hyperfine”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Retractable Technologies | $33.90 million | 0.64 | -$7.01 million | ($0.12) | -6.00 |
| Hyperfine | $11.40 million | 8.39 | -$35.57 million | ($0.38) | -2.37 |
Analyst Recommendations
This is a breakdown of current recommendations and price targets for Retractable Technologies and Hyperfine, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Retractable Technologies | 0 | 0 | 0 | 0 | 0.00 |
| Hyperfine | 1 | 1 | 3 | 0 | 2.40 |
Hyperfine has a consensus price target of $2.03, suggesting a potential upside of 125.47%. Given Hyperfine’s stronger consensus rating and higher probable upside, analysts plainly believe Hyperfine is more favorable than Retractable Technologies.
Insider and Institutional Ownership
7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 15.0% of Hyperfine shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by insiders. Comparatively, 26.3% of Hyperfine shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares Retractable Technologies and Hyperfine’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Retractable Technologies | -41.11% | -17.15% | -9.33% |
| Hyperfine | -210.75% | -97.88% | -61.81% |
Risk & Volatility
Retractable Technologies has a beta of 1.22, suggesting that its share price is 22% more volatile than the S&P 500. Comparatively, Hyperfine has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500.
Summary
Retractable Technologies beats Hyperfine on 8 of the 14 factors compared between the two stocks.
About Retractable Technologies
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
About Hyperfine
Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
